Literature DB >> 30625027

Emergence of CMY-2-Producing Escherichia coli in Korean Layer Parent Stock.

Kwang Won Seo1, Jong Bo Shim2, Young Ju Lee1.   

Abstract

The use of antimicrobials in food animals is the major determinant for the propagation of resistant bacteria in the animal reservoir. Especially, parent stock (PS) produces thousands of eggs for commercial laying hens and can transfer a variety of viral and bacterial agents to chicks. The objective of this study was to investigate the presence and distribution of third-generation cephalosporin-resistant and extended-spectrum β-lactamase (ESBL)- and plasmid-mediated AmpC (pAmpC)-producing Escherichia coli in the PS level of the layer operation system in Korea. A total of 591 E. coli isolates were tested in this study and resistance to the first-generation cephalosporins ranged from 60.0% to 71.1%, whereas the resistance to the second- and third-generation cephalosporins ranged from 18.3% to 28.9% and from 8.3% to 14.5%, respectively. Of the 65 third-generation cephalosporin-resistant E. coli isolates, 51 (78.5%) showed multidrug resistance and 18 (27.7%) exhibited phenotypic and genotypic characteristics of ESBL/pAmpC-producing E. coli. With regard to ESBL/pAmpC gene prevalence, only the CMY-2 gene was identified in all 18 ESBL/pAmpC-producing E. coli and two isolates possessed both the CMY-2 and TEM-1 genes. Pulsed-field gel electrophoresis (PFGE) analysis of the 18 CMY-2-producing E. coli isolates revealed four PFGE patterns from the same PS farm and flock and accorded both CMY-2 genes and antimicrobial resistance pattern. To the best of our knowledge, this is the first study to investigate the prevalence and characteristics of third-generation cephalosporin-resistant and CMY-2-producing E. coli isolated at the layer PS level; our findings support the critical need for a comprehensive surveillance program to monitor the emergence and dissemination of third-generation cephalosporin resistance.

Entities:  

Keywords:  CMY-2; antimicrobial resistance; layer parent stock; third-generation cephalosporin

Mesh:

Substances:

Year:  2019        PMID: 30625027     DOI: 10.1089/mdr.2018.0254

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  3 in total

1.  Characterization of Beta-Lactamases in Bloodstream-Infection Escherichia coli: Dissemination of blaADC - 162 and blaCMY- 2 Among Bacteria via an IncF Plasmid.

Authors:  Linlin Xiao; Xiaotong Wang; Nana Kong; Long Zhang; Mei Cao; Muzhen Sun; Quhao Wei; Weiwei Liu
Journal:  Front Microbiol       Date:  2019-10-01       Impact factor: 5.640

2.  Molecular epidemiology of cefotaxime-resistant but ceftazidime-susceptible Enterobacterales and evaluation of the in vitro bactericidal activity of ceftazidime and cefepime.

Authors:  Martín L Marchisio; Karen I Liebrenz; Emilce de Los A Méndez; José A Di Conza
Journal:  Braz J Microbiol       Date:  2021-07-16       Impact factor: 2.214

3.  Antibiotic Administration Routes and Oral Exposure to Antibiotic Resistant Bacteria as Key Drivers for Gut Microbiota Disruption and Resistome in Poultry.

Authors:  Yang Zhou; Yu Li; Lu Zhang; Zuowei Wu; Ying Huang; He Yan; Jiang Zhong; Li-Ju Wang; Hafiz M Abdullah; Hua H Wang
Journal:  Front Microbiol       Date:  2020-07-07       Impact factor: 5.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.